These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31707827)

  • 21. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Hennigan B; Berry C; Collison D; Corcoran D; Eteiba H; Good R; McEntegart M; Watkins S; McClure JD; Mangion K; Ford TJ; Petrie MC; Hood S; Rocchiccioli P; Shaukat A; Lindsay M; Oldroyd KG
    Heart; 2020 May; 106(10):758-764. PubMed ID: 32114516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of stress echocardiography for risk stratification of patients after percutaneous coronary intervention.
    Cortigiani L; Sicari R; Bigi R; Gherardi S; Rigo F; Gianfaldoni ML; Landi P; Bovenzi F; Picano E
    Am J Cardiol; 2008 Nov; 102(9):1170-4. PubMed ID: 18940286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).
    Budoff MJ; Mayrhofer T; Ferencik M; Bittner D; Lee KL; Lu MT; Coles A; Jang J; Krishnam M; Douglas PS; Hoffmann U;
    Circulation; 2017 Nov; 136(21):1993-2005. PubMed ID: 28847895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Nishi T; Piroth Z; De Bruyne B; Jagic N; Möbius-Winkler S; Kobayashi Y; Derimay F; Fournier S; Barbato E; Tonino P; Jüni P; Pijls NHJ; Fearon WF
    Circulation; 2018 Oct; 138(17):1797-1804. PubMed ID: 30354650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.
    Čelutkienė J; Burneikaitė G; Shkolnik E; Jakutis G; Vajauskas D; Čerlinskaitė K; Zuozienė G; Petrauskienė B; Puronaitė R; Komiagienė R; Butkuvienė I; Steponėnienė R; Misiūra J; Laucevičius A
    Cardiovasc Ultrasound; 2019 Jul; 17(1):13. PubMed ID: 31272465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COURAGE, ORBITA, and ISCHEMIA: Percutaneous Coronary Intervention for Stable Coronary Artery Disease.
    Teoh Z; Al-Lamee RK
    Interv Cardiol Clin; 2020 Oct; 9(4):469-482. PubMed ID: 32921371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
    Khan S; Fawaz S; Simpson R; Robertson C; Kelly P; Mohdnazri S; Tang K; Cook CM; Gallagher S; O'Kane P; Spratt J; Brilakis ES; Karamasis GV; Al-Lamee R; Keeble TR; Davies JR
    Front Cardiovasc Med; 2023; 10():1172763. PubMed ID: 37206100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of speckle tracking during dobutamine stress echocardiography in patients with chronic stable angina.
    Farag SI; El-Rabbat KEE; Ahmed Mostafa S; Abd Alnaby MS; Sabry AM
    Indian Heart J; 2020; 72(1):40-45. PubMed ID: 32423559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rethinking revascularization in patients with stable angina.
    Harskamp RE; Park DW
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):159-161. PubMed ID: 29338462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
    Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Reynolds HR; Picard MH; Spertus JA; Peteiro J; Lopez Sendon JL; Senior R; El-Hajjar MC; Celutkiene J; Shapiro MD; Pellikka PA; Kunichoff DF; Anthopolos R; Alfakih K; Abdul-Nour K; Khouri M; Bershtein L; De Belder M; Poh KK; Beltrame JF; Min JK; Fleg JL; Li Y; Maron DJ; Hochman JS
    Circulation; 2021 Sep; 144(13):1008-1023. PubMed ID: 34058845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Echocardiography-dobutamine test in the short-term evaluation of the results of coronary angioplasty].
    Lanzarini L; Fetiveau R; Previtali M; Poli A; Mussini A; Ferrario M; Bramucci E; Montemartini C
    G Ital Cardiol; 1994 Feb; 24(2):107-14. PubMed ID: 8013762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease.
    Wester M; Koll F; Luedde M; Langer C; Resch M; Luchner A; Müller K; Zeman F; Koller M; Maier LS; Sossalla S
    Clin Res Cardiol; 2023 Sep; 112(9):1194-1203. PubMed ID: 36100700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS.
    Schwartz JB; Caputo G; Abbott J
    J Am Geriatr Soc; 1993 Sep; 41(9):967-74. PubMed ID: 8409183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Dobutamine Stress Echocardiography Using Speckle-Tracking Analysis versus Conventional Visual Analysis for Detection of Significant Coronary Artery Disease after ST-Segment Elevation Myocardial Infarction.
    Joyce E; Hoogslag GE; Al Amri I; Debonnaire P; Katsanos S; Bax JJ; Delgado V; Marsan NA
    J Am Soc Echocardiogr; 2015 Dec; 28(12):1379-89.e1. PubMed ID: 26307373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention.
    Furtado RHM; Fagundes AA; Oyama K; Zelniker TA; Tang M; Kuder JF; Murphy SA; Hamer A; Wang H; Keech AC; Giugliano RP; Sabatine MS; Bergmark BA
    Circ Cardiovasc Interv; 2022 Mar; 15(3):e011382. PubMed ID: 35209731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
    Ono M; Serruys PW; Garg S; Kawashima H; Gao C; Hara H; Lunardi M; Wang R; O'Leary N; Wykrzykowska JJ; Piek JJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Noack T; Mohr FW; Davierwala PM; Spertus JA; Cohen DJ; Onuma Y;
    Circulation; 2022 Oct; 146(17):1268-1280. PubMed ID: 35862109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
    Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
    Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial.
    Hartley A; Shun-Shin M; Caga-Anan M; Rajkumar C; Nowbar AN; Foley M; Francis DP; Haskard DO; Khamis RY; Al-Lamee RK
    Front Cardiovasc Med; 2021; 8():757030. PubMed ID: 34708098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.